Colorado Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Hold |
479
| – | – | 0.08% | 100 |
|
|
2025
Q1 | $238K | Sell |
479
-8
| -2% | -$3.98K | 0.11% | 88 |
|
|
2024
Q4 | $253K | Sell |
487
-127
| -21% | -$66K | 0.12% | 83 |
|
|
2024
Q3 | $380K | Sell |
614
-13
| -2% | -$8.05K | 0.19% | 76 |
|
|
2024
Q2 | $347K | Sell |
627
-7
| -1% | -$3.87K | 0.19% | 80 |
|
|
2024
Q1 | $368K | Sell |
634
-9
| -1% | -$5.22K | 0.21% | 69 |
|
|
2023
Q4 | $341K | Sell |
643
-84
| -12% | -$44.5K | 0.22% | 60 |
|
|
2023
Q3 | $368K | Hold |
727
| – | – | 0.28% | 55 |
|
|
2023
Q2 | $379K | Buy |
727
+1
| +0.1% | +$521 | 0.28% | 53 |
|
|
2023
Q1 | $418K | Sell |
726
-33
| -4% | -$19K | 0.32% | 52 |
|
|
2022
Q4 | $417K | Sell |
759
-47
| -6% | -$25.8K | 0.35% | 49 |
|
|
2022
Q3 | $408K | Hold |
806
| – | – | 0.35% | 47 |
|
|
2022
Q2 | $438K | Hold |
806
| – | – | 0.36% | 47 |
|
|
2022
Q1 | $476K | Hold |
806
| – | – | 0.34% | 47 |
|
|
2021
Q4 | $541K | Sell |
806
-11
| -1% | -$7.38K | 0.36% | 46 |
|
|
2021
Q3 | $466K | Sell |
817
-291
| -26% | -$166K | 0.33% | 50 |
|
|
2021
Q2 | $558K | Sell |
1,108
-1
| -0.1% | -$504 | 0.38% | 48 |
|
|
2021
Q1 | $506K | Buy |
1,109
+250
| +29% | +$114K | 0.36% | 48 |
|
|
2020
Q4 | $399K | Hold |
859
| – | – | 0.29% | 53 |
|
|
2020
Q3 | $379K | Sell |
859
-191
| -18% | -$84.3K | 0.31% | 51 |
|
|
2020
Q2 | $378K | Hold |
1,050
| – | – | 0.33% | 51 |
|
|
2020
Q1 | $297K | Sell |
1,050
-90
| -8% | -$25.5K | 0.28% | 53 |
|
|
2019
Q4 | $370K | Sell |
1,140
-263
| -19% | -$85.4K | 0.26% | 57 |
|
|
2019
Q3 | $408K | Hold |
1,403
| – | – | 0.31% | 56 |
|
|
2019
Q2 | $412K | Buy |
+1,403
| New | +$412K | 0.31% | 57 |
|